Teachers Advisors’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding HRTX
TCM
BBA
ACH
Teachers Advisors's HRTX Position: Q1 2019 in Review
Teachers Advisors increased its Heron Therapeutics (HRTX) stake by 10% in Q1 2019, buying an estimated $644K and bringing the position to 264,496 shares worth $6.46M. The position accounts for 0.01% of the portfolio, ranked #1244.
Teachers Advisors first reported a position in HRTX in Q2 2014 and has held it in 20 quarters since. The position peaked at $8.92M in Q2 2018. 198 funds tracked by Wall St. Rank hold HRTX as of Q1 2019.
- Teachers Advisors held 264,496 shares of Heron Therapeutics worth $6.46M as of Q1 2019.
- Teachers Advisors bought 24,605 Heron Therapeutics shares in Q1 2019, an estimated $644K.
- Heron Therapeutics made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #1244 holding.
- Teachers Advisors first reported a position in Heron Therapeutics in Q2 2014 and has held it in 20 quarters since.
- Teachers Advisors's Heron Therapeutics position peaked at $8.92M in Q2 2018.
- 198 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2019.
Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.